HNRNPA2B1 and plasma cell myeloma: S/BS) (Figure 2H) and bone formation rate (Figure 2I-J) in the mice injected with myeloma cells expressing high levels of hnRNPA2B1 (shCtrl or A2B1) than in those injected with low hnRNPA2B1 myeloma cells (shA2B1 or Vec).